Mod GRF 1-29 & Ipamorelin Blend (10mg) Research Peptide

Product Introduction

Mod GRF 1-29 & Ipamorelin Blend (10mg) is a research-grade peptide blend supplied by Core Peptides for laboratory and scientific research applications. This formulation combines Mod GRF 1-29, also known as modified GRF 1-29, with Ipamorelin in a single research product. The blend provides researchers with two distinct peptide materials for controlled experimental investigations involving peptide signaling and receptor-related pathways.

Each vial contains a total of 10mg of peptide blend. The product is supplied with an emphasis on quality, consistency, and reliable laboratory research. Mod GRF 1-29 & Ipamorelin Blend (10mg) is intended exclusively for scientific research and is not intended for human or veterinary use.

What Is Mod GRF 1-29 & Ipamorelin?

Mod GRF 1-29 is a modified peptide sequence related to growth hormone-releasing hormone research, while Ipamorelin belongs to a class of synthetic peptides investigated for their interactions with specific cellular receptors.

Combining two peptide materials in a research formulation allows scientists to investigate their individual and combined behavior within controlled experimental systems. Researchers can examine peptide interactions, signaling mechanisms, receptor activity, and related molecular processes.

The combination is particularly relevant to laboratory research where investigators want to study multiple peptide pathways within the same experimental framework.

Research Applications

Mod GRF 1-29 & Ipamorelin Blend (10mg) may be relevant to research involving peptide signaling, receptor biology, molecular biology, and endocrine-related research.

Laboratory studies may investigate peptide-receptor interactions, downstream signaling pathways, molecular responses, and other biochemical mechanisms. Researchers can use appropriate in-vitro models, biochemical assays, or analytical techniques depending on the objectives of their study.

The exact experimental concentration, methodology, controls, and handling procedures should be determined by qualified researchers according to their validated laboratory protocols.

Product Specifications

Quality and Consistency

Reproducible research depends on consistent laboratory materials. Mod GRF 1-29 & Ipamorelin Blend (10mg) is supplied with a focus on quality, consistency, and suitability for controlled scientific investigation.

Researchers should review applicable product and batch documentation when evaluating the blend for a particular experiment. Appropriate analytical methods, controls, and validated laboratory procedures should be used when studying peptide materials and their interactions.

Packaging and Handling

Each Mod GRF 1-29 & Ipamorelin Blend (10mg) product is securely packaged to help protect the research material during storage and transportation.

Researchers should follow applicable product documentation and established laboratory procedures for receiving, storage, handling, and preparation. Appropriate laboratory safety practices should always be followed when working with research peptides.

Why Choose Core Peptides?

Core Peptides provides research-focused peptide materials for laboratories, researchers, and scientific investigations. This Mod GRF 1-29 & Ipamorelin Blend (10mg) offers researchers a convenient way to obtain two distinct research peptides in a single formulation.

Clear product identification, quantity information, research-use positioning, and secure packaging help researchers evaluate the material for their specific experimental requirements.

Research Use Disclaimer

Mod GRF 1-29 & Ipamorelin Blend (10mg) is supplied strictly for laboratory and scientific research purposes. It is not approved or intended for human consumption, self-administration, diagnosis, treatment, prevention, or mitigation of any disease or medical condition. It is not intended for veterinary use. Researchers are responsible for complying with applicable laws, institutional requirements, laboratory safety standards, and appropriate handling procedures.

Product Features

• Contains 10mg total peptide blend
• Combines Mod GRF 1-29 and Ipamorelin
• Research-grade peptide material
• Suitable for controlled laboratory research
• Relevant to peptide and receptor research
• Quality-focused production
• Securely packaged
• For research use only
• Not for human or veterinary use

Reference:

1. Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149–S159. https://doi.org/10.21037/tau.2019.11.30
2. Yin, Y., Li, Y., & Zhang, W. (2014). The growth hormone secretagogue receptor: its intracellular signaling and regulation. International journal of molecular sciences, 15(3), 4837–4855. https://doi.org/10.3390/ijms15034837
3. Bill, C. A., & Vines, C. M. (2020). Phospholipase C. Advances in experimental medicine and biology, 1131, 215–242. https://doi.org/10.1007/978-3-030-12457-1_9
4. Greenwood-Van Meerveld, B., Tyler, K., Mohammadi, E., & Pietra, C. (2012). Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus. Journal of experimental pharmacology, 4, 149–155. https://doi.org/10.2147/JEP.S35396
5. Lall, S., Tung, L. Y., Ohlsson, C., Jansson, J. O., & Dickson, S. L. (2001). Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochemical and biophysical research communications, 280(1), 132–138. https://doi.org/10.1006/bbrc.2000.4065
6. Svensson, J., Lall, S., Dickson, S. L., Bengtsson, B. A., Rømer, J., Ahnfelt-Rønne, I., Ohlsson, C., & Jansson, J. O. (2000). The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. The Journal of endocrinology, 165(3), 569–577. https://doi.org/10.1677/joe.0.1650569